Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

NimbleRx

Explore full profile

Provides a pharmacy experience centered around the patient's needs to provide a more streamlined workflow

Redwood City, United StatesFounded 2014Biotech & Life Sciences
Valuation $100–250M Last recorded · 2022
Revenue $10–50M Latest reported FY
Headcount 100–500 Current team size
Total funding $50–100M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for NimbleRx and the history behind them.

About NimbleRx

NimbleRx operates in the healthcare technology sector, providing a comprehensive platform for pharmacies to manage prescriptions, refills, payments, and deliveries. The company serves both independent and chain pharmacies, aiming to streamline their operations and improve patient care. NimbleRx's business model revolves around offering a subscription-based service that integrates seamlessly with existing pharmacy systems. This platform allows pharmacies to efficiently handle prescription orders, automate refills, manage compliance, and execute marketing strategies. By doing so, NimbleRx helps pharmacies reduce operational costs, increase revenue, and enhance customer satisfaction. The company generates revenue through subscription fees and potentially transaction-based charges for certain services. NimbleRx operates primarily in the United States, targeting pharmacies that seek to modernize their operations and offer better service to their patients. The platform is designed to be user-friendly, ensuring that pharmacists can easily adopt and utilize its features without extensive training. Key features include 24/7 prescription management, secure information storage, and options for discreet delivery or in-store pickup. NimbleRx also provides robust customer support to address any questions or issues that pharmacies might encounter. Overall, NimbleRx positions itself as a vital partner for pharmacies looking to enhance their operational efficiency and patient care capabilities.

Source: Dealroom company data

At a glance

Status
Acquired
Founded
2014
Headquarters
Redwood City, United States
Employees
170
Open positions
7
Dealroom signal
80.5/100
Industry
Health
Sub-industry
Pharmaceutical, BioTechnology
Sector
Biotech & Life Sciences, Pharmacy, Biotechnology, Biotech and Pharma, Hard Tech, YC W15
Business model
Marketplace & ecommerce
Client focus
b2c

Funding history

8 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
ACQUISITIONOther financing May 2026 $0 — Swoop ↗
LATE VCOther financing Jul 2022 $25M $100M Undisclosed ↗
Showing the latest 2 of 8 recorded eventsBook a demo for the full funding history →

Financials

Revenue over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

YearRevenueGrowth
2026
2025
2024
2023
2022
2021
2020 —
Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

NimbleRx website traffic

Latest recorded traffic for NimbleRx is 2.2M monthly website visits, up 15.8% over the last three months. NimbleRx's team declined 5.6% over the past year.

Latest monthly visits2.2M 3-month web change+15.8% 1-year team growth-5.6%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Open positions

Openings linked to this company in Dealroom
1 distinct opening shownExplore hiring signals →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

9 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed2 investors entered at this stage

Series A5 investors entered at this stage

Series B and later1 investor entered at this stage

  • Four Rivers Group

Other known investors1 additional known investor

  • Swoop
Team profiled 19 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
4 countries with
team presence
🇺🇸 United States91.4%
🇨🇦 Canada7.2%
🇯🇵 Japan0.7%
🇬🇧 United Kingdom0.7%
4 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about NimbleRx on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See NimbleRx’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.